{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:53:49Z","timestamp":1793969629176,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.critrevonc.2024.104558","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:55:13Z","timestamp":1731689713000},"page":"104558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The prevalence of solid tumors and hematologic malignancies among patients with Down syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"205","author":[{"given":"Nayara Rozalem","family":"Moretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz Nardelli da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Vieira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian de Paula","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Arthur Cerqueira","family":"Taumaturgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Gabrielli Silva","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francinny Alves","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Cezar Aquino de","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104558_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/1008-682X.128514","article-title":"Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients","volume":"17","author":"Accardo","year":"2015","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.critrevonc.2024.104558_bib2","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/jcm10204687","article-title":"Aging with Down syndrome\u2014where are we now and where are we going?","volume":"10","author":"Alldred","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2024.104558_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7454","key":"10.1016\/j.critrevonc.2024.104558_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"GRADE Working Group. Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.morpho.2012.10.001","article-title":"Trisomy 21 and cancers","volume":"96","author":"Ayed","year":"2012","journal-title":"Morphologie"},{"key":"10.1016\/j.critrevonc.2024.104558_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54157","article-title":"Assessment of cancer predisposition syndromes in a National Cohort of Children With a Neoplasm","volume":"6","author":"Bakhuizen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2024.104558_bib7","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2468-2667(23)00057-9","article-title":"Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records","volume":"8","author":"Baksh","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.critrevonc.2024.104558_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7210","article-title":"Cancer risks related to intellectual disabilities: a systematic review","volume":"13","author":"Banda","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2024.104558_bib9","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3324\/haematol.2023.283225","article-title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","volume":"108","author":"Baruchel","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2024.104558_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ijc.20532","article-title":"Down\u2019s syndrome protects against breast cancer: is a constitutional cell microenvironment the key?","volume":"113","author":"B\u00e9nard","year":"2005","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104558_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/1055-9965.EPI-07-2630","article-title":"Cancer risk in children with birth defects and in their families: a population based Cohort study of 5.2 million children from Norway and Sweden","volume":"17","author":"Bj\u00f8rge","year":"2008","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"10.1016\/j.critrevonc.2024.104558_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2005-0697","article-title":"Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses","volume":"91","author":"Bojesen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2024.104558_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13633-020-00088-0","article-title":"Klinefelter syndrome and germ cell tumors: review of the literature","volume":"2020","author":"Bonouvrie","year":"2020","journal-title":"Int J. Pedia Endocrinol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069077","article-title":"Cancer risk in children and adolescents with birth defects: a population-based Cohort study","volume":"8","author":"Botto","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.critrevonc.2024.104558_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.17294\/2330-0698.1824","article-title":"Prevalence of common disease conditions in a large Cohort of individuals with Down syndrome in the United States","volume":"8","author":"Chicoine","year":"2021","journal-title":"J. Patient Cent. Res Rev."},{"key":"10.1016\/j.critrevonc.2024.104558_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bdra.23364","article-title":"Risk of cancer among children with birth defects: a novel approach","volume":"103","author":"Dawson","year":"2015","journal-title":"Birth Defects Res A Clin. Mol. Teratol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.critrevonc.2024.104558_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bmj.308.6941.1393","article-title":"Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group","volume":"308","author":"Forman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib19","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2021.6","article-title":"Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view","volume":"23","author":"Hasaart","year":"2021","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.critrevonc.2024.104558_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026604","article-title":"CanCHD study of hematopoietic cancers in children with and without genetic syndromes","volume":"13","author":"Hasan","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.critrevonc.2024.104558_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","article-title":"Pattern of malignant disorders in individuals with Down\u2019s syndrome","volume":"2","author":"Hasle","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2024.104558_bib23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet Med."},{"key":"10.1016\/j.critrevonc.2024.104558_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.1995.85","article-title":"Cancer incidence in men with Klinefelter syndrome","volume":"71","author":"Hasle","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104558_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/35012518","article-title":"The DNA sequence of human chromosome 21","volume":"405","author":"Hattori","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2024.104558_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.30126","article-title":"Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a National Cohort study","volume":"139","author":"Ji","year":"2016","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104558_bib28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/cancers16061103","article-title":"Cancer risk in patients with down syndrome-a retrospective Cohort study from Germany","volume":"16","author":"Krieg","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104558_bib29","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/s41375-020-0854-5","article-title":"Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome","volume":"34","author":"Laurent","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2024.104558_bib30","first-page":"172","article-title":"Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2024.104558_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1055-9965.EPI-14-1181","article-title":"Immune-related conditions and acute leukemia in children with Down syndrome: a Children\u2019s Oncology Group report","volume":"24","author":"Linabery","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.critrevonc.2024.104558_bib32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaoncol.2019.1215","article-title":"Association between birth defects and cancer risk among children and adolescents in a population-based assessment of 10 million live births","volume":"5","author":"Lupo","year":"2019","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104558_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.gyobfe.2016.02.016","article-title":"Cancer du sein et trisomie 21: une anomalie g\u00e9n\u00e9tique qui prot\u00e8ge contre le cancer du sein","volume":"44","author":"Martel-Billard","year":"2016","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertil. \u00e9"},{"key":"10.1016\/j.critrevonc.2024.104558_bib34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/oxfordjournals.aje.a116720","article-title":"Risk of childhood cancer for infants with birth defects: I. A record\u2013linkage study, Atlanta, Georgia, 1968\u20131988","volume":"137","author":"Mili","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/oxfordjournals.aje.a116721","article-title":"Risk of CHildhood Cancer for Infants with Birth Defects: II. A record\u2013linkage study, Iowa, 1983\u20131989","volume":"137","author":"Mili","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179006","article-title":"Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013","volume":"12","author":"Norwood","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.critrevonc.2024.104558_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jar.12446","article-title":"Early death and causes of death of people with Down syndrome: a systematic review","volume":"31","author":"O\u2019Leary","year":"2018","journal-title":"J. Appl. Res. Intellect. Disabil. JARID"},{"key":"10.1016\/j.critrevonc.2024.104558_bib38","unstructured":"Page, M.J., Higgins, J.P., Sterne, J.A., 2023. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 [WWW Document]. URL \u3008https:\/\/training.cochrane.org\/handbook\/current\/chapter-13\u3009 (accessed 8.15.24)."},{"key":"10.1016\/j.critrevonc.2024.104558_bib39","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.21518","article-title":"Cancer incidence of persons with Down syndrome in Finland: a population-based study","volume":"118","author":"Patja","year":"2006","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104558_bib41","doi-asserted-by":"crossref","first-page":"15325","DOI":"10.3390\/ijms242015325","article-title":"Hematologic neoplasms associated with Down syndrome: Cellular and molecular heterogeneity of the diseases","volume":"24","author":"Peroni","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104558_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/genes14040800","article-title":"Inverse comorbidity between Down syndrome and solid tumors: Insights from in silico analyses of Down syndrome critical region genes","volume":"14","author":"Fosu","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2024.104558_bib43","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104558_bib44","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3324\/haematol.2023.283225","article-title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","volume":"108","author":"Baruchel","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2024.104558_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.103783","article-title":"Cancer screening in adults with down syndrome, a proposal","volume":"63","author":"Rethor\u00e9","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2024.104558_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12961-019-0435-0","article-title":"Supporting implementation of Cochrane methods in complex communication reviews: resources developed and lessons learned for editorial practice and policy","volume":"17","author":"Ryan","year":"2019","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.critrevonc.2024.104558_bib47","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/bmj.324.7346.1155","article-title":"Breast screening guidelines should be adapted in Down\u2019s syndrome","volume":"324","author":"Satg\u00e9","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib48","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.3389\/fimmu.2018.03058","article-title":"The pattern of malignancies in Down syndrome and its potential context with the immune system","volume":"9","author":"Satg\u00e9","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib49","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104558_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2788.2006.00862.x","article-title":"The profile and incidence of cancer in Down syndrome","volume":"51","author":"Sullivan","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.critrevonc.2024.104558_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/EJE-20-0702","article-title":"Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy","volume":"184","author":"Viuff","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2024.104558_bib52","doi-asserted-by":"crossref","unstructured":"Winestone LE, Bhojwani D, Ghorashian S, Muffly L, Leahy AB, Chao K, Steineck A, R\u00f6ssig C, Lamble A, Maude SL, Myers R, Rheingold SR. INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Jan;30(1):56-70. doi: 10.1016\/j.jtct.2023.10.005. Epub 2023 Oct 10. PMID: 37821078.","DOI":"10.1016\/j.jtct.2023.10.005"},{"key":"10.1016\/j.critrevonc.2024.104558_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2353\/jmoldx.2009.080132","article-title":"Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology","volume":"11","author":"Xavier","year":"2009","journal-title":"J. Mol. Diagn"},{"key":"10.1016\/j.critrevonc.2024.104558_bib54","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","article-title":"Mortality associated with Down\u2019s syndrome in the USA from 1983 to 1997: a population-based study","volume":"359","author":"Yang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2024.104558_bib55","article-title":"CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges","author":"Zhang","year":"2022","journal-title":"Front Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T03:23:48Z","timestamp":1734405828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"alternative-id":["S1040842824003019"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104558","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of solid tumors and hematologic malignancies among patients with Down syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104558"}}